VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC
Share · US92532F1003 · VRTX · 882807 (XNAS)
Overview Financial Indicators
452,98 USD
-1,24 % -5,71 USD
NASDAQ (XETR) · Current prices and charts at MoneyPeak
13.06.2025 07:40

Current Prices from VERTEX PHARMACEUTICALS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
VX1.DE
EUR
13.06.2025 07:40
394,50 EUR
395,15 EUR
-0,16 %
XNAS: NASDAQ
NASDAQ
VRTX
USD
12.06.2025 21:03
458,69 USD
452,44 USD
+1,38 %
XLON: London
London
0QZU.L
USD
12.06.2025 18:14
458,91 USD
452,44 USD
+1,43 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-1,24 % 0,55 % 3,10 % -8,57 % -2,40 % -5,59 % 68,67 %

Company Profile for VERTEX PHARMACEUTICALS INC Share

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Invested Funds

The following funds have invested in: VERTEX PHARMACEUTICALS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
1.695,46
Percentage (%)
3,98 %
Fund
iShares Edge MSCI World Minimum Volatility ESG UCITS ETF EUR Hedged (Acc)
Vol. in million
645,34
Percentage (%)
1,14 %
Fund
iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. in million
1.478,90
Percentage (%)
1,14 %
Fund
iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. in million
19.976,49
Percentage (%)
1,14 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in million
1.137,69
Percentage (%)
1,10 %

Company Data

Name VERTEX PHARMACEUTICALS INC
Company Vertex Pharmaceuticals Incorporated
Symbol VRTX
Website https://www.vrtx.com
Primary Exchange XNAS NASDAQ
WKN 882807
ISIN US92532F1003
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Reshma Kewalramani FASN, M.D.
Market Capitalization 110 Mrd.
Country United States of America
Currency USD
Employees 6,1 T
Address 50 Northern Avenue, 02210 Boston
IPO Date 2007-12-28

Stock Splits

Date Split
24.08.2000 2:1

Ticker Symbols

Name Symbol
Frankfurt VX1.F
London 0QZU.L
NASDAQ VRTX
XETRA VX1.DE

More Shares

Investors who VERTEX PHARMACEUTICALS INC hold also have the following shares in their portfolio:
ADOBE INC
ADOBE INC Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMAZON.CO INC
AMAZON.CO INC Share
ANTHEM 21/31
ANTHEM 21/31 Bond
APPLE INC
APPLE INC Share
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Share
CELGENE 13/23
CELGENE 13/23 Bond
IS.S.E.600 BA.RE.U.ETF A.
IS.S.E.600 BA.RE.U.ETF A. ETF
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NVIDIA CORP
NVIDIA CORP Share
PAYPAL INC
PAYPAL INC Share
TESLA INC
TESLA INC Share
XTR.IE-N.100E. 1CDLA
XTR.IE-N.100E. 1CDLA ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025